Molecular Vehicles for Targeted Drug Delivery
- 12 April 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 13 (3) , 462-467
- https://doi.org/10.1021/bc0155770
Abstract
Targeted drug delivery by cell-specific cytokines and antibodies promises greater drug efficacy and reduced side effects. We describe a novel strategy for assembly of drug delivery vehicles that does not require chemical modification of targeting proteins. The strategy relies on a noncovalent binding of standardized “payload” modules to targeting proteins expressed with a “docking” tag. The payload modules are constructed by linking drug carriers to an adapter protein capable of binding to a docking tag. Using fragments of bovine ribonuclease A as an adapter protein and a docking tag, we have constructed vascular endothelial growth factor (VEGF) based vehicles for gene delivery and for liposome delivery. Assembled vehicles displayed remarkable selectivity in drug delivery to cells overexpressing VEGF receptors. We expect that our strategy can be employed for targeted delivery of many therapeutic or imaging agents by different recombinant targeting proteins.Keywords
This publication has 13 references indexed in Scilit:
- Targeting Endothelial Cells Overexpressing VEGFR-2: Selective Toxicity of Shiga-like Toxin−VEGF Fusion ProteinsBioconjugate Chemistry, 2001
- Functionally Active VEGF Fusion ProteinsProtein Expression and Purification, 2001
- Bispecific and bifunctional single chain recombinant antibodiesBiomolecular Engineering, 2001
- Molecular vehicle for target-mediated delivery of therapeutics and diagnosticsJournal of Controlled Release, 2001
- Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral VectorsJournal of Histochemistry & Cytochemistry, 2000
- Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugsPharmacology & Therapeutics, 1999
- In Vitro Gene Delivery to Hepatocytes with Galactosylated PolyethylenimineBioconjugate Chemistry, 1997
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995
- Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.The Journal of Experimental Medicine, 1994
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993